Influence of Renal Function on Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Romosozumab

por Hsu, Cheng‐Pang, Maddox, Judy, Block, Geoffrey, Bartley, Yessenia, Yu, Zhigang
Publicado 2022

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension

por Miyauchi, Akimitsu, Dinavahi, Rajani V., Crittenden, Daria B., Yang, Wenjing, Maddox, Judy C., Hamaya, Etsuro, Nakamura, Yoichi, Libanati, Cesar, Grauer, Andreas, Shimauchi, Junichiro
Publicado 2019

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

por Schemitsch, Emil H., Miclau, Theodore, Karachalios, Theofilos, Nowak, Lauren L., Sancheti, Parag, Poolman, Rudolf W., Caminis, John, Daizadeh, Nadia, Dent-Acosta, Ricardo E., Egbuna, Ogo, Chines, Arkadi, Maddox, Judy, Grauer, Andreas, Bhandari, Mohit
Publicado 2020

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

por Baek, Ki-Hyun, Chung, Yoon-Sok, Koh, Jung-Min, Kim, In Joo, Kim, Kyoung Min, Min, Yong-Ki, Park, Ki Deok, Dinavahi, Rajani, Maddox, Judy, Yang, Wenjing, Kim, Sooa, Lee, Sang Jin, Cho, Hyungjin, Lim, Sung-Kil
Publicado 2021